News

Former officials combine forces to blast march-in rights

Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework

WTO appears close to rejecting a proposed waiver on patents for Covid diagnostics and therapies

KFF Health News: Morning Briefing

Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows

Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say

Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing

AI adds urgency to patent debate

Special council works to protect and promote STEM excellence

#27 Jamie Simpson | The U.S. policy perspective on SEPs

Apple Keeps Chasing the Ultimate Health-Tracking Watch—but It Could Take Years

Scroll to Top